Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
The new antiviral agent, azidothymidine (AZT; BW A509U), is currently the only successful drug in use for patients with acquired immunodeficiency syndrome. The effect of this thymidine analog, 3'-azido-3'-deoxythymidine, on the replication of the lymphadenopathy-associated virus strain of the human...
Gespeichert in:
| Veröffentlicht in: | J Virol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1987
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC255991/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2446006/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.61.12.3769-3773.1987 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
